DexCom
DXCM
84.30
+0.91
+1.09%
DexCom
US · DXCM
#635 by market cap
Listed 2005
84.30
+0.91
+1.09%
Live - 5344 symbols - heartbeat 515s ago
· 2026-10-08 07:27
Pre-market
84.24
-0.07%
After-hours
84.30
0.00%
Overnight
84.24
-0.07%
- Market cap
- 31.81B
- P/E (TTM)i
- 33.32
- P/Bi
- 12.13
- EPSi
- 2.09
- Div yieldi
- 0.00%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on DXCM?
Anonymous reader poll. Unscientific, not investment advice.
About DexCom
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
- Founded
- 1999
- CEO
- Mr. Jacob S. Leach
- Employees
- 11,100
- Headquarters
- San Diego, California, United States of America
- Fiscal year end
- 12-31
- Website
- dexcom.com
Company profile
- Exchange
- US
- Symbol
- DXCM
- Market-cap rank
- #635
- Listing date
- 2005-04-14
- Market cap
- 31.81B
- Float cap
- 31.70B
- Shares out
- 377.36M
- Float shares
- 376.00M
Sectors & themes
Medical Devices
Internet of Things
Best Growth Stocks
Global medical industry
Regular Savings Plan
Fractional Shares JP
Quote time 2026-10-08 07:27:32 · For reference only, not investment advice and not tailored to your situation.